Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch-like protein 25 (KLHL25) is a substrate-specific adapter in CUL3-based E3 ubiquitin ligase complexes, facilitating the ubiquitination and proteasomal degradation of target proteins. It plays a role in translation homeostasis and regulation of lipid synthesis via its modulation of ACLY, a key enzyme in fatty acid metabolism. KLHL25 is implicated in the differentiation of regulatory T cells by reprogramming fatty acid metabolic pathways. Like other Kelch-like family members, it contains a BTB domain, a BACK domain, and multiple Kelch motifs that mediate protein-protein interactions. Dysregulation of KLHL25 and related family members has been linked to cancer and other metabolic or genetic diseases, although specific roles and therapeutic applications are still under investigation[1][3][5][6][7].
Targeting the ubiquitin-proteasome pathway via modulation or inhibition of substrate recognition/adaptor activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like protein 25 (KLHL25).